Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1982-9-17
pubmed:abstractText
The in vitro susceptibility of 20 isolates of Clostridium difficile to cefotaxime, moxalactam, and cefoperazone was determined by a standard agar dilution method. The median minimal inhibitory concentrations were 64, 32, and 32 mug/ml for cefotaxime, moxalactam, and cefoperazone, respectively.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6285817-429542, http://linkedlifedata.com/resource/pubmed/commentcorrection/6285817-485125, http://linkedlifedata.com/resource/pubmed/commentcorrection/6285817-501864, http://linkedlifedata.com/resource/pubmed/commentcorrection/6285817-6455967, http://linkedlifedata.com/resource/pubmed/commentcorrection/6285817-6456884, http://linkedlifedata.com/resource/pubmed/commentcorrection/6285817-6456890, http://linkedlifedata.com/resource/pubmed/commentcorrection/6285817-6457555, http://linkedlifedata.com/resource/pubmed/commentcorrection/6285817-665627, http://linkedlifedata.com/resource/pubmed/commentcorrection/6285817-6973951, http://linkedlifedata.com/resource/pubmed/commentcorrection/6285817-7233892, http://linkedlifedata.com/resource/pubmed/commentcorrection/6285817-7253364, http://linkedlifedata.com/resource/pubmed/commentcorrection/6285817-7325628, http://linkedlifedata.com/resource/pubmed/commentcorrection/6285817-7396460, http://linkedlifedata.com/resource/pubmed/commentcorrection/6285817-988896
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
846-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1982
pubmed:articleTitle
In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't